4 results on '"Mario Fuentealba S."'
Search Results
2. Factores asociados a respuesta favorable de tratamiento corticoidal en pacientes con polirradiculoneuropatía desmielinizante inflamatoria crónica
- Author
-
Gonzalo Klaassen P., Aldo Vera-Calzaretta, Cristhian Pérez-Villalobos, Ignacio Molina D., Mario Fuentealba S., Sergio Juica A., and Alexis González-Burboa
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Corticosteroid treatment ,Polyradiculoneuropathy ,Retrospective cohort study ,Therapeutics ,General Medicine ,Disease ,medicine.disease ,Methods observational ,Polyradiculoneuropathy, Chronic Inflammatory Demyelinating ,Corticosteroid therapy ,Internal medicine ,medicine ,Corticosteroids ,In patient ,Plasmapheresis ,business - Abstract
Background: The treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is based on corticosteroids, immunoglobulin and plasmapheresis. In our Health System, corticosteroids are commonly used as first line therapy for economic reasons and accessibility. However, the factors associated with a good response are not well known. Aim: To assess the association of demographic, clinical and laboratory variables with a favorable response to corticosteroid therapy in patients with CIDP. Material and Methods: Observational, descriptive, longitudinal and retrospective study of 33 patients with a diagnosis of typical, definitive or probable CIDP, treated with corticosteroids for at least six months. Results: Twenty-three patients had a good clinical response to corticosteroid treatment and 10 were non-responders. The variables significantly associated with a good response to steroids were a disease lasting less than 1 year prior to the start of treatment, the absence of axonal damage in electromyography a relapsing-recurrent course and a favorable response within two months of treatment. Conclusions: Most of these patients with CIDP had good response to corticosteroid therapy.
- Published
- 2020
3. Miastenia gravis: resultados inmediatos y alejados de la timectomía transesternal extendida
- Author
-
Jorge Canales Z, Mario Fuentealba S., Enrique Seguel S, René Saldías F, Andrés Jadue T, Alberto Fuentes E, Alejandra Riquelme U., Roberto González L, Aleck Stockins L, and Emilio Alarcón C
- Subjects
medicine.medical_specialty ,Medical treatment ,business.industry ,medicine.medical_treatment ,Thoracic Surgery ,General Medicine ,Perioperative ,medicine.disease ,Thymectomy ,Myasthenia gravis ,Surgery ,Cardiothoracic surgery ,Severity of illness ,Myasthenia Gravis ,medicine ,Thymus hyperplasia ,Thymus Hyperplasia ,Young adult ,business - Abstract
Background: Thymectomy improves clinical outcomes and decreases the need for medical treatment in patients with myasthenia gravis (MG). Aim: To describe the immediate and long-term results of extended transsternal thymectomy (ETT) in patients with MG. Material and Methods: A review of databases, surgical protocols, clinical records and interviews of patients subjected to extended transsternal thymectomy for MG between 1990 and 2016. Perioperative clinical characteristics, anticholinesterase treatment, immediate and remote surgical results were analyzed and patients were followed from one to 10years. Results: We studied 58 patients aged 35 ± 14years (72%) women. In the preoperative period, according to Osserman classification, nine patients (15,5%) were in grade I, eight (13,8%) in grade IIA 8 and 40 (69%) in grade IIB. The pathological study of the surgical piece showed thymic hyperplasia in 39 cases (67,2%). Four patients had postoperative complications but none died. In the Follow-up at 1, 3, 5, 8 and 10years the Masaoka palliation rate was 71.7, 77.5, 67.7, 70.0 and 70,6% respectively. The figures for remission rate were 13.0, 15.0,19.4, 35.0 and 35,3% respectively. The figures for Zielinski positive results were 79.6, 87.5, 87.1, 90.0 and 82,4% respectively. The DeFilippi score improved by 80.4, 87.5, 87.1, 90.0 and 82.4% respectively. The Myasthenia Gravis Foundation of America Post-Intervention State improved by 67.4, 77.5, 77.5, 75.0 and 70,6% respectively. Mean Myasthenia Gravis Activities of daily living (MGADL) and Myasthenia Gravis Quality of life scale 15 (MGQOL 15) were 1.65 and 6.31 respectively. Conclusions: In selected patients with MG, extended transsternal thymectomy in MG has good immediate and long-term results.
- Published
- 2018
4. [Results of extended transsternal thymectomy for Myasthenia gravis. Experience with 58 patients]
- Author
-
Roberto, González L, Alejandra, Riquelme U, Mario, Fuentealba S, Jorge, Canales Z, Alberto, Fuentes E, René, Saldías F, Enrique, Seguel S, Aleck, Stockins L, Andrés, Jadue T, and Emilio, Alarcón C
- Subjects
Adult ,Male ,Time Factors ,Adolescent ,Middle Aged ,Thymectomy ,Severity of Illness Index ,Young Adult ,Treatment Outcome ,Myasthenia Gravis ,Humans ,Female ,Longitudinal Studies ,Aged ,Follow-Up Studies - Abstract
Thymectomy improves clinical outcomes and decreases the need for medical treatment in patients with myasthenia gravis (MG).To describe the immediate and long-term results of extended transsternal thymectomy (ETT) in patients with MG.A review of databases, surgical protocols, clinical records and interviews of patients subjected to extended transsternal thymectomy for MG between 1990 and 2016. Perioperative clinical characteristics, anticholinesterase treatment, immediate and remote surgical results were analyzed and patients were followed from one to 10years.We studied 58 patients aged 35 ± 14years (72%) women. In the preoperative period, according to Osserman classification, nine patients (15,5%) were in grade I, eight (13,8%) in grade IIA 8 and 40 (69%) in grade IIB. The pathological study of the surgical piece showed thymic hyperplasia in 39 cases (67,2%). Four patients had postoperative complications but none died. In the Follow-up at 1, 3, 5, 8 and 10years the Masaoka palliation rate was 71.7, 77.5, 67.7, 70.0 and 70,6% respectively. The figures for remission rate were 13.0, 15.0,19.4, 35.0 and 35,3% respectively. The figures for Zielinski positive results were 79.6, 87.5, 87.1, 90.0 and 82,4% respectively. The DeFilippi score improved by 80.4, 87.5, 87.1, 90.0 and 82.4% respectively. The Myasthenia Gravis Foundation of America Post-Intervention State improved by 67.4, 77.5, 77.5, 75.0 and 70,6% respectively. Mean Myasthenia Gravis Activities of daily living (MGADL) and Myasthenia Gravis Quality of life scale 15 (MGQOL 15) were 1.65 and 6.31 respectively.In selected patients with MG, extended transsternal thymectomy in MG has good immediate and long-term results.
- Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.